David Cole to Breast Neoplasms
This is a "connection" page, showing publications David Cole has written about Breast Neoplasms.
Connection Strength
1.388
-
Detection of mammaglobin mRNA in peripheral blood is associated with high grade breast cancer: interim results of a prospective cohort study. BMC Cancer. 2008 Feb 20; 8:55.
Score: 0.152
-
Predictors of cosmetic outcome following MammoSite breast brachytherapy: a single-institution experience of 100 patients with two years of follow-up. Int J Radiat Oncol Biol Phys. 2007 Jun 01; 68(2):354-8.
Score: 0.143
-
Molecular detection of micrometastatic breast cancer in histopathology-negative axillary lymph nodes correlates with traditional predictors of prognosis: an interim analysis of a prospective multi-institutional cohort study. Ann Surg. 2004 Jun; 239(6):828-37; discussion 837-40.
Score: 0.118
-
The molecular detection of micrometastatic breast cancer. Am J Surg. 2003 Oct; 186(4):351-8.
Score: 0.112
-
Quantitative real-time RT-PCR detection of breast cancer micrometastasis using a multigene marker panel. Int J Cancer. 2001 Jul 15; 93(2):162-71.
Score: 0.096
-
Prognostic factors for residual occult disease in shave margins during partial mastectomy. Breast Cancer Res Treat. 2021 Sep; 189(2):471-481.
Score: 0.096
-
Detection of occult breast cancer micrometastases in axillary lymph nodes using a multimarker reverse transcriptase-polymerase chain reaction panel. J Am Coll Surg. 1998 Jul; 187(1):9-16.
Score: 0.078
-
Efficacy of reverse transcriptase-polymerase chain reaction screening for micrometastic disease in axillary lymph nodes of breast cancer patients. Am Surg. 1998 Jun; 64(6):539-43; discussion 543-4.
Score: 0.078
-
Phase I study of recombinant CEA vaccinia virus vaccine with post vaccination CEA peptide challenge. Hum Gene Ther. 1996 Jul 10; 7(11):1381-94.
Score: 0.068
-
Molecular detection of micrometastatic breast cancer in histopathology-negative axillary lymph nodes fails to predict breast cancer recurrence: a final analysis of a prospective multi-institutional cohort study. Ann Surg Oncol. 2010 Oct; 17 Suppl 3:312-20.
Score: 0.046
-
Six-year experience: long-term disease control outcomes for partial breast irradiation using MammoSite balloon brachytherapy. Am J Surg. 2010 Feb; 199(2):204-9.
Score: 0.043
-
A quantitative reverse transcription-PCR assay for rapid, automated analysis of breast cancer sentinel lymph nodes. J Mol Diagn. 2009 Nov; 11(6):576-82.
Score: 0.043
-
Incidence and prognostic factors for seroma development after MammoSite breast brachytherapy. Brachytherapy. 2008 Oct-Dec; 7(4):305-9.
Score: 0.040
-
Increased circulating myeloid-derived suppressor cells correlate with clinical cancer stage, metastatic tumor burden, and doxorubicin-cyclophosphamide chemotherapy. Cancer Immunol Immunother. 2009 Jan; 58(1):49-59.
Score: 0.039
-
A rapid, fully automated, molecular-based assay accurately analyzes sentinel lymph nodes for the presence of metastatic breast cancer. Ann Surg. 2006 Mar; 243(3):389-98.
Score: 0.033
-
Molecular analysis improves sensitivity of breast sentinel lymph node biopsy: results of a multi-institutional prospective cohort study. Surgery. 2005 Sep; 138(3):474-81.
Score: 0.032
-
An innovative microarray strategy identities informative molecular markers for the detection of micrometastatic breast cancer. Clin Cancer Res. 2005 May 15; 11(10):3697-704.
Score: 0.031
-
EpCAM is overexpressed in breast cancer and is a potential target for breast cancer gene therapy. Cancer Res. 2004 Aug 15; 64(16):5818-24.
Score: 0.030
-
Molecular detection of breast cancer cells in the peripheral blood of advanced-stage breast cancer patients using multimarker real-time reverse transcription-polymerase chain reaction and a novel porous barrier density gradient centrifugation technology. Clin Cancer Res. 2003 Oct 15; 9(13):4865-71.
Score: 0.028
-
Factors influencing choice between mastectomy and lumpectomy for women in the Carolinas. J Surg Oncol. 2001 Jan; 76(1):6-12.
Score: 0.023
-
A Multifaceted Approach to Opioid Education, Prescribing, and Disposal for Patients with Breast Cancer Undergoing Surgery. J Surg Res. 2021 01; 257:597-604.
Score: 0.023
-
The potential role for prolactin-inducible protein (PIP) as a marker of human breast cancer micrometastasis. Br J Cancer. 1999 Nov; 81(6):1002-8.
Score: 0.021
-
Identification of MART-1-specific T-cell receptors: T cells utilizing distinct T-cell receptor variable and joining regions recognize the same tumor epitope. Cancer Res. 1994 Oct 15; 54(20):5265-8.
Score: 0.015